ÇÐȸ¼Ò°³ ÇÐȸÁÖ°ü½Ã»ó

1. Çмú»ó (KSMCB Academic Research Awards)

 
Á¦22ȸ ¼ö»óÀÚ (2023³â) Á¦21ȸ ¼ö»óÀÚ (2022³â) Á¦20ȸ ¼ö»óÀÚ (2021³â)
Á¦19ȸ ¼ö»óÀÚ (2020³â) Á¦18ȸ ¼ö»óÀÚ (2019³â) Á¦17ȸ ¼ö»óÀÚ (2018³â) Á¦16ȸ ¼ö»óÀÚ (2017³â)
Á¦15ȸ ¼ö»óÀÚ (2016³â) Á¦14ȸ ¼ö»óÀÚ (2015³â) Á¦13ȸ ¼ö»óÀÚ (2014³â) Á¦12ȸ ¼ö»óÀÚ (2013³â)
Á¦11ȸ ¼ö»óÀÚ (2012³â) Á¦10ȸ ¼ö»óÀÚ (2011³â) Á¦9ȸ ¼ö»óÀÚ (2010³â) Á¦8ȸ ¼ö»óÀÚ (2009³â)
Á¦7ȸ ¼ö»óÀÚ (2008³â) Á¦6ȸ ¼ö»óÀÚ (2007³â) Á¦5ȸ ¼ö»óÀÚ (2006³â) Á¦4ȸ ¼ö»óÀÚ (2005³â)
Á¦3ȸ ¼ö»óÀÚ (2004³â) Á¦2ȸ ¼ö»óÀÚ (2003³â) Á¦1ȸ ¼ö»óÀÚ (2002³â) ¸ñ¾Ï»ý¸í°úÇлó
(1994³â-2000³â)
Çѱ¹ºÐÀÚ·¼¼Æ÷»ý¹°ÇÐȸ Çмú»ó »ý¸í°úÇлó ¼ö»óÀÚ
Á¤Á¾°æ (¼­¿ï´ëÇб³ »ý¸í°úÇкÎ)

Jongkyeong (JK) Chung is a professor of School of Biological Sciences and also a member of Institute of Molecular Biology and Genetics at Seoul National University. He received his B.S. and M.S. degrees from Seoul National University and earned a Ph.D. degree in cell biology from Harvard University in 1993. During his graduate studies, he firstly demonstrated S6 kinase as a target of PI3 kinase and rapamycin. After completing his postdoctoral research at Dana-Farber Cancer Institute (DFCI) and Harvard Medical School, he joined the faculty of Korea Advanced Institute of Science and Technology (KAIST) in 1996 and served as a professor until 2009. Since he established his own lab, he has been using both mammalian cell system and Drosophila genetics to understand the regulatory mechanism of cell growth and metabolism. His group has generated many important loss-of-function and gain-of-function Drosophila models for PI3 kinase pathway, MAP kinase pathways, TOR pathway, LKB1/AMPK pathway, and p53 pathway to characterize the pathways. Representatively, they include null mutants for p53, RSK, MKP3, PDK1, TOR, FOXO, LKB1, AMPK, and TRAFs. In addition, he has been interested in understanding the pathological mechanism of genetic Parkinson's disease (PD). His group has generated first relevant animal models for PD genes such as Parkin, PINK1, DJ-1, and LRRK2. Using these disease models, his group discovered that two independent PD genes, PINK1 and Parkin genetically and functionally interact and make a novel signaling pathway to control mitochondrial remodeling process. This seminal finding provided a completely new concept for understanding pathological mechanism of both genetic and sporadic PD. Based on these scientific achievements, he has won various awards and honors, such as "Scientist of the Month Award" from Korean government (2006), "Best Research Award" from KAIST (2008), and "Kyung-Ahm Academic Award" (2008).

Representative papers
-Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. (2006) Nature 441, 1157-1161.
-Energy-dependent regulation of cell structure by AMP-activated protein kinase. (2007) Nature 447, 1017-1020.
-A metazoan ortholog of SpoT hydrolyzes ppGpp and plays a role in starvation responses. (2010) Nature Structural Molecular Biology 17, 1188-1194.
   

Çѱ¹ºÐÀÚ·¼¼Æ÷»ý¹°ÇÐȸ Çмú»ó Molecules and Cells (M&C) ¿ì¼ö³í¹®»ó ¼ö»óÀÚ

±èÆòÇö (°­¿ø´ëÇб³ ÀÇ»ý¸í°úÇдëÇÐ ºÐÀÚ»ý¸í°úÇаú)


¼ö»ó ³í¹®
The PKA/CREB pathway is closely involved in VEGF expression in mouse macrophages. (2007). Mol Cells 23, 23-29.

±èÆòÇö ±³¼ö´Â Á¡¸·IgAÇ×ü »ý¼ºÁ¶Àý°ú Á¡¸·¸é¿ª Ç׻󼺿¡ °üÇÑ ¿¬±¸¸¦ ÁßÁ¡ÀûÀ¸·Î ¼öÇàÇÏ°í ÀÖ´Ù. ƯÈ÷ TGF-b¿¡ ÀÇÇÑ IgA »ý¼º°ú VEGF ¹ßÇö ±âÀÛÀ» ½ÅÈ£Àü´Þ/Àü»çÁ¶Àý ¼öÁØ¿¡¼­ ±Ô¸íÇÏ´Â ¿¬±¸¸¦ ´Ù³â°£ ¼öÇàÇÏ¿´´Ù. Mol Cells (23: 23-29)¿¡ °ÔÀçµÈ ³í¹®¿¡¼­´Â cAMP-dependent PKA°¡ CREBÀ» È°¼ºÈ­½ÃÅ°¾î VEGF À¯ÀüÀÚ ¹ßÇöÀ» À¯µµÇÑ´Ù´Â Çö»ó°ú, VEGF promoter¿¡ Á¸ÀçÇÏ´Â CREB °áÇÕºÎÀ§¸¦ ±Ô¸íÇÏ¿´´Ù. ±è ±³¼ö ¿¬±¸ÁøÀÌ ÃÖÃʷΠŬ·Î´×ÇÑ ¸¶¿ì½º VEGF promoter reporter (J Leuko Biol 81:557-566)´Â ÀÌ ºÐ¾ßÀÇ ¸¹Àº ¿¬±¸±×·ì¿¡°Ô Á¦°øµÇ°í ÀÖ´Ù. º» ³í¹®Àº Mol CellsÀÇ ¼öÁØÀ» Çâ»ó½ÃÅ°´Âµ¥ ±â¿©ÇÏ¿´±â¿¡ 2010³âµµ Çѱ¹ºÐÀÚ¼¼Æ÷»ý¹°ÇÐȸ <Çмú»ó M&C¿ì¼ö³í¹®»ó>À» ¼ö¿©ÇÑ´Ù.

   

Àüü¸Þ´º

´Ý±â

Ä«Å×°í¸®º° Àüü ¸Þ´º¸¦ È®ÀÎÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.